The Swedes were right about lockdowns, masks, and other Wuhan stuff, too.

The Swedish National Board of Health and Welfare (NBHW) published new treatment guidelines for youth with gender dysphoria last week that explicitly instruct medical providers that psychosocial support should be the first line of treatment. The updated guidelines follow a 2021 policy change that jettisoned the use of puberty blockers and cross-sex hormones to treat gender dysphoric youth, outside of a clinical research setting.

“Psychosocial support that helps the young person live with the body’s pubertal development without medication needs to be the first option when choosing care measures,” the guidelines read, according to the Society for Evidence-based Gender Medicine.

The NBHW “deems that the risks of puberty suppressing treatment with GnRH-analogues and gender-affirming hormonal treatment currently outweigh the possible benefits, and that the treatments should be offered only in exceptional cases.”